Webinar:Dyslipidemia in CKD: Mechanisms, Consequences and Treatment Options by Stage

This webinar will present the mechanisms, consequences and treatment options for dyslipidemia in Chronic Kidney Disease. 


Description of the Webinar

This webinar will touch on the following subjects:

– Incidence of mortality and cardiovascular disease as a function of residual renal function

– Alterations in lipoprotein structure and composition associated with loss of kidney function

– Epidemiologic associations of lipid levels and distribution and outcomes in patients with kidney failure

– Association of Lp (a) levels and outcomes

– Association of lipoprotein oxidation and outcomes

– Effect of interventional studies with antioxidants as contrasted to the epidemiologic association between lipoprotein oxidation and outcomes

– Effects of interventional approaches to cardiovascular outcomes as a function of residual renal function

– Effects of cardiovascular events

– Effects on all-cause mortality


Webinar Webcast: 

When: This webinar was held on Friday December 5th, 2014 – 3:00 PM – 4:00 PM CET (Brussels/Paris), 9:00 AM – 10:00 AM EST (New York/Bogota/Lima).

For those who missed the webinar they can view the video webcast here: 

About the Facilitators


George A. Kaysen, MD is Professor of Emeritus Medicine and has served as Chief of the Nephrology Division at UC Davis, for 22 years and Acting Chairman of Biochemistry and Molecular Medicine for 6 years. Dr. Kaysen has done extensive research on nutrition, inflammation, albumin synthesis and catabolism, and lipoprotein biochemistry both in patients and in experimental renal disease in animals. He participated in the NIH United States Renal Data System (USRDS) Nutrition Special Studies Center for over 10 years and was responsible for developing the biorepository and conducting all biochemical analysis generated by those studies in the area of nutrition, inflammation, vascular disease and functional outcomes. His current area of research is in the structure and function of lipoproteins in patients with different stages of chronic kidney disease.



Additional Info

  • Language:
  • Contains Audio:
  • Content Type:
  • Source:
  • Event:
    Other events
  • Year:
  • Members Only:

Read 1353 times

Last modified on Monday, 19 October 2015 19:29

Scroll to Top